Filed by AcelRx Pharmaceuticals, Inc.
(Commission File No. 001-35068)
pursuant to Rule 425 under the Securities Act of 1933
and deemed filed pursuant to Rule 14a-12
under the Securities Exchange Act of 1934
Subject Company: Tetraphase Pharmaceutials, Inc.
(Commission File No. 001-35837
![](https://capedge.com/proxy/425/0001437749-20-006097/slide01.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide02.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide03.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide04.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide05.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide06.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide07.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide08.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide09.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide10.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide11.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide12.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide13.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide14.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide15.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide16.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide17.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide18.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide19.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide20.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide21.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide22.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide23.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide24.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide25.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide26.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide27.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide28.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide29.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide30.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide31.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide32.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide33.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide34.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide35.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide36.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide37.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide38.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide39.jpg)
![](https://capedge.com/proxy/425/0001437749-20-006097/slide40.jpg)